Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-06-05 Regulatory Filings
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
113年年報及股東會資料 — 2024_1760_20240524F02.pdf
Regulatory Filings
2024-06-05 Chinese
113年年報及股東會資料 — 2024_1760_20240524F13.pdf
AGM Information Classification · 95% confidence The document is titled as reference materials for the Annual General Meeting (AGM) of the company 寶齡富錦生技股份有限公司, scheduled on May 24, 2024. It includes agenda items such as approval of the 2023 business report and financial statements, profit distribution, and discussion on lifting competition restrictions for directors. The content is typical of materials shared during an AGM to inform shareholders about the meeting agenda and proposals. The document length is under 5,000 characters and it serves as meeting reference materials rather than the full annual report or financial statements themselves. Therefore, it fits the category of AGM Information (AGM-R).
2024-06-05 Chinese
113年年報及股東會資料 — 2024_1760_20240524FE1.pdf
AGM Information Classification · 95% confidence The document is an announcement for the 2024 Annual General Shareholders' Meeting of Panion & BF Biotech Inc. It includes the meeting time, venue, and agenda items such as the business report, audit committee's review, remuneration distribution, dividend distribution, and proposals to be discussed. The document does not contain the actual reports or financial statements but rather informs shareholders about the meeting details and agenda. The document length is short (1030 characters), and it serves as a notice for the AGM rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R).
2024-06-05 Chinese
113年年報及股東會資料 — 2024_1760_20240524F01.pdf
AGM Information Classification · 100% confidence The document is a detailed notice and related materials for the 113th Annual General Meeting (AGM) of shareholders of 寶齡富錦生技股份有限公司. It includes the meeting date, agenda items such as the 112年度營業報告 (business report), financial statements, dividend distribution, and other shareholder meeting matters. It also contains proxy forms, instructions for shareholders, locations for proxy solicitation, and dividend payment instructions. The content is focused on informing shareholders about the AGM and facilitating their participation and voting. There is no full financial report or earnings data presented, nor is it a transcript or a legal proceeding update. The document is not a report publication announcement but the actual meeting materials and notices. Therefore, it fits the category of AGM Information (AGM-R).
2024-06-05 Chinese
公告本公司113年股東常會決議解除董事競業禁止限制
Board/Management Information Classification · 95% confidence The document is a public announcement from a listed company (1760 寶齡富錦) regarding a shareholder meeting resolution to lift restrictions on directors engaging in competitive business activities. It includes details about the meeting date, directors involved, the nature of the competitive activities allowed, and voting results. The document is short (1041 characters) and focuses on a specific board/management-related decision rather than financial results or reports. It does not contain financial statements or detailed financial data. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions related to the company's board or senior management.
2024-05-24 Chinese
公告本公司現金股利發放公告
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (885 characters) from a company regarding the distribution of cash dividends, including details such as dividend amounts, ex-dividend dates, and payment dates. It does not contain financial statements or detailed financial analysis but rather provides information about dividend payments to shareholders. This fits the definition of a Notice of Dividend Amount (DIV).
2024-05-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.